Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John K Field

Showing results (51-60 of 258) with videos related to

Pageof 26
Sort By:
Patient Education and Counseling|March 10, 2017
The role of screening expectations in modifying short-term psychological responses to low-dose computed tomography lung cancer screening among high-risk individualsCharlotte E Dunn, Adrian Edwards, Ben Carter, et al.
The Journal of Pathology. Clinical Research|August 25, 2025
Assessing PD-L1 expression in non-small cell lung carcinoma: a prospective study of matched fine-needle aspirates, core biopsies, and resection specimens using alcohol and forming fixativesAlexander Haragan, Natalie Kipling, Michael Shackcloth, et al.
International Journal of Oncology|May 9, 2015
Trends and regional variation in the incidence of head and neck cancers in England: 2002 to 2011Caroline E McCarthy, John K Field, Bijaya P Rajlawat, et al.
Investigative Ophthalmology & Visual Science|February 26, 2003
Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survivalAndrea G M Scholes, Bertil E Damato, Janice Nunn, et al.
Cancer Letters|May 2, 2012
Epigenetic biomarkers in lung cancerTriantafillos Liloglou, Naiara G Bediaga, Benjamin R B Brown, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment responseAlexander Haragan, John K Field, Michael P A Davies, et al.
ESMO Open|November 2, 2019
Implementation of lung cancer screening in Europe: challenges and potential solutions: summary of a multidisciplinary roundtable discussionJohn K Field, Harry deKoning, Mattijs Oudkerk, et al.
Expert Review of Anticancer Therapy|October 16, 2009
Use of lung cancer risk models in planning research and service programs in CT screening for lung cancerStephen W Duffy, Olaide Y Raji, Olorunsola F Agbaje, et al.
Ebiomedicine|June 28, 2023
Plasma protein biomarkers for early prediction of lung cancerMichael P A Davies, Takahiro Sato, Haitham Ashoor, et al.
Journal of Cancer Research and Clinical Oncology|March 5, 2017
COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancerUrszula Oleksiewicz, Triantafillos Liloglou, Kalliopi-Maria Tasopoulou, et al.
Pageof 26

Showing results (51-60 of 258) with videos related to

Sort By:
Pageof 26
Patient Education and Counseling|March 10, 2017
The role of screening expectations in modifying short-term psychological responses to low-dose computed tomography lung cancer screening among high-risk individualsCharlotte E Dunn, Adrian Edwards, Ben Carter, et al.
The Journal of Pathology. Clinical Research|August 25, 2025
Assessing PD-L1 expression in non-small cell lung carcinoma: a prospective study of matched fine-needle aspirates, core biopsies, and resection specimens using alcohol and forming fixativesAlexander Haragan, Natalie Kipling, Michael Shackcloth, et al.
International Journal of Oncology|May 9, 2015
Trends and regional variation in the incidence of head and neck cancers in England: 2002 to 2011Caroline E McCarthy, John K Field, Bijaya P Rajlawat, et al.
Investigative Ophthalmology & Visual Science|February 26, 2003
Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survivalAndrea G M Scholes, Bertil E Damato, Janice Nunn, et al.
Cancer Letters|May 2, 2012
Epigenetic biomarkers in lung cancerTriantafillos Liloglou, Naiara G Bediaga, Benjamin R B Brown, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment responseAlexander Haragan, John K Field, Michael P A Davies, et al.
ESMO Open|November 2, 2019
Implementation of lung cancer screening in Europe: challenges and potential solutions: summary of a multidisciplinary roundtable discussionJohn K Field, Harry deKoning, Mattijs Oudkerk, et al.
Expert Review of Anticancer Therapy|October 16, 2009
Use of lung cancer risk models in planning research and service programs in CT screening for lung cancerStephen W Duffy, Olaide Y Raji, Olorunsola F Agbaje, et al.
Ebiomedicine|June 28, 2023
Plasma protein biomarkers for early prediction of lung cancerMichael P A Davies, Takahiro Sato, Haitham Ashoor, et al.
Journal of Cancer Research and Clinical Oncology|March 5, 2017
COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancerUrszula Oleksiewicz, Triantafillos Liloglou, Kalliopi-Maria Tasopoulou, et al.
Pageof 26